In a rare move, the Supreme Court of Florida has asked for a second round of oral arguments in the Florigrown matter. As we wrote about here, this case will determine whether Florida’s medical marijuana licensing framework, which effectively requires vertical integration by each licensee, is constitutional.
Read MoreIt is hard to underestimate the impact that the coronavirus and its related fallout—economic and otherwise—will have on the cannabis industry. Some of that impact will be decidedly negative. For instance, as we wrote about recently, cash is harder to come by for cannabis companies right now.
Read MoreAs we arrive at the middle of June, the Illinois Department of Financial and Professional Regulation (IDFPR) has not issued any conditional adult-use cannabis dispensary licenses and, as we recently wrote about here, it may be a while before the licenses are issued. Nevertheless, those licenses will be issued eventually, and it is important that cannabis entrepreneurs begin evaluating their next steps.
Read MoreFull disclosure: David Belsky is a personal friend (don’t hold it against him) and his company, FlowerHire, is a firm client. He is also one of the foremost authorities on placing talent in the regulated cannabis and hemp industries. Earlier this week, Forbes posted a great interview with Belsky that we highly recommend.
Read MoreFor years we have been intrigued about the prospect of legal recreational marijuana in Florida—not a particularly far-fetched notion given the overwhelming support for Florida’s 2016 constitutional amendment broadly legalizing medical marijuana in the state.
Read MoreThe preliminary reports were great. Cannabis shops were deemed “essential businesses” in several states, and according to The Motley Fool “[d]uring the first few weeks of [March], cannabis sales were soaring and spiked around the middle of the month as fears heightened that people would be confined to their homes in an effort to fight the coronavirus pandemic.”
Read MoreMarijuana sales in Colorado totaled nearly $1.75 billion in 2019 according to data released by the Department of Revenue’s Marijuana Enforcement Division. The $1,747,990,628 in sales includes both recreational and medical marijuana and is a sizeable increase from 2018, when sales totaled $1,545,691,080.
Read MoreIn November, we wrote about a lawsuit filed against Amazon by a New Jersey man claiming he was wrongfully terminated due to a failed marijuana drug test despite being a patient in the state’s medical marijuana program. Now, New Jersey state lawmakers have advanced a bill that would require workers’ compensation to cover medical marijuana.
Read More
